Legal & General Group’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.36M Buy
244,037
+16,240
+7% +$245K ﹤0.01% 1697
2025
Q4
$4.11M Buy
227,797
+13,563
+6% +$244K ﹤0.01% 1666
2025
Q3
$3.97M Sell
214,234
-5,686
-3% -$89.3K ﹤0.01% 1692
2025
Q2
$3.52M Buy
219,920
+45,576
+26% +$812K ﹤0.01% 1709
2025
Q1
$3.39M Buy
174,344
+14,121
+9% +$297K ﹤0.01% 1707
2024
Q4
$3.53M Buy
160,223
+48,047
+43% +$925K ﹤0.01% 1745
2024
Q3
$1.89M Buy
112,176
+6,967
+7% +$103K ﹤0.01% 2000
2024
Q2
$1.26M Buy
105,209
+53,626
+104% +$599K ﹤0.01% 2119
2024
Q1
$572K Buy
51,583
+6,055
+13% +$61.8K ﹤0.01% 2379
2023
Q4
$394K Buy
45,528
+2,100
+5% +$16.3K ﹤0.01% 2541
2023
Q3
$332K Buy
43,428
+20,228
+87% +$152K ﹤0.01% 2591
2023
Q2
$167K Buy
23,200
+16,603
+252% +$96.8K ﹤0.01% 2771
2023
Q1
$40.2K Hold
6,597
﹤0.01% 2915
2022
Q4
$28.8K Buy
6,597
+1,364
+26% +$6.09K ﹤0.01% 3060
2022
Q3
$21K Hold
5,233
﹤0.01% 3189
2022
Q2
$27K Hold
5,233
﹤0.01% 3136
2022
Q1
$33K Buy
+5,233
New +$34.7K ﹤0.01% 3095

Other funds holding CLBT